Starting this year, the Department of Health and Human Services will begin negotiations with drug companies to lower the price of Part D drugs in Medicare, according to HHS Secretary Xavier Becerra.
The 10 Part D drugs that will be negotiated will be published on September 1, according to Centers for Medicare and Medicaid Services Administrator Chiquita Brooks-LaSure. On September 1, 2024, CMS will publish the fair prices for these drugs, she said.
